Integer Holdings Co. (NYSE:ITGR) Shares Purchased by Bamco Inc. NY

Bamco Inc. NY grew its stake in Integer Holdings Co. (NYSE:ITGR - Free Report) by 17.4% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 254,377 shares of the medical equipment provider's stock after purchasing an additional 37,700 shares during the period. Bamco Inc. NY owned about 0.76% of Integer worth $33,069,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Contravisory Investment Management Inc. increased its position in shares of Integer by 55.9% during the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider's stock worth $29,000 after purchasing an additional 80 shares in the last quarter. Huntington National Bank raised its holdings in Integer by 8,933.3% in the 3rd quarter. Huntington National Bank now owns 271 shares of the medical equipment provider's stock valued at $35,000 after acquiring an additional 268 shares during the last quarter. Quest Partners LLC lifted its stake in Integer by 3,688.9% in the 2nd quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider's stock worth $39,000 after purchasing an additional 332 shares in the last quarter. GAMMA Investing LLC boosted its holdings in shares of Integer by 60.9% during the 2nd quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider's stock worth $43,000 after purchasing an additional 142 shares during the last quarter. Finally, Innealta Capital LLC acquired a new position in Integer during the second quarter worth $110,000. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on ITGR. KeyCorp lifted their target price on shares of Integer from $139.00 to $144.00 and gave the stock an "overweight" rating in a research note on Tuesday, October 15th. Citigroup increased their price objective on Integer from $124.00 to $130.00 and gave the stock a "neutral" rating in a research report on Tuesday, October 1st. Piper Sandler restated an "overweight" rating and issued a $140.00 target price (up previously from $125.00) on shares of Integer in a research report on Friday, October 25th. Bank of America increased their price target on Integer from $135.00 to $145.00 and gave the stock a "buy" rating in a report on Tuesday, October 1st. Finally, Benchmark increased their target price on shares of Integer from $130.00 to $140.00 and gave the stock a "buy" rating in a research note on Monday, October 21st. One investment analyst has rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $142.00.

Integer Stock Up 1.0 %

Shares of Integer stock traded up $1.43 during trading on Tuesday, hitting $140.20. 51,784 shares of the stock were exchanged, compared to its average volume of 306,297. The stock has a market cap of $4.70 billion, a price-to-earnings ratio of 42.82, a price-to-earnings-growth ratio of 2.02 and a beta of 1.12. The firm's 50-day moving average price is $131.59 and its 200 day moving average price is $124.64. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.28 and a quick ratio of 2.09. Integer Holdings Co. has a 12-month low of $86.42 and a 12-month high of $142.00.

Integer (NYSE:ITGR - Get Free Report) last issued its earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.07. The business had revenue of $431.42 million for the quarter, compared to analyst estimates of $440.59 million. Integer had a return on equity of 11.63% and a net margin of 6.70%. The business's quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter last year, the company earned $1.27 EPS. As a group, analysts forecast that Integer Holdings Co. will post 5.33 earnings per share for the current fiscal year.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.